Jeffrey A Whitnell - Net Worth and Insider Trading
Jeffrey A Whitnell Net Worth
The estimated net worth of Jeffrey A Whitnell is at least $0 dollars as of 2024-11-13. Jeffrey A Whitnell is the Director of Elite Pharmaceuticals Inc and owns about 0 shares of Elite Pharmaceuticals Inc (ELTP) stock worth over $0. Details can be seen in Jeffrey A Whitnell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffrey A Whitnell has not made any transactions after 2011-02-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jeffrey A Whitnell
Jeffrey A Whitnell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey A Whitnell owns 2 companies in total, including Elite Pharmaceuticals Inc (ELTP) , and Akorn Inc (AKRXQ) .
Click here to see the complete history of Jeffrey A Whitnell’s form 4 insider trades.
Insider Ownership Summary of Jeffrey A Whitnell
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ELTP | Elite Pharmaceuticals Inc | 2013-03-07 | director |
| AKRXQ | Akorn Inc | 2009-04-20 | director & Interim CEO/CFO |
Jeffrey A Whitnell Latest Holdings Summary
Jeffrey A Whitnell currently owns a total of 1 stock. Jeffrey A Whitnell owns 0 shares of Elite Pharmaceuticals Inc (ELTP) as of February 3, 2011, with a value of $0.
Latest Holdings of Jeffrey A Whitnell
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ELTP | Elite Pharmaceuticals Inc | 2011-02-03 | 0 | 0.58 | 0 |
Holding Weightings of Jeffrey A Whitnell
Jeffrey A Whitnell Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey A Whitnell has made a total of 0 transactions in Elite Pharmaceuticals Inc (ELTP) over the past 5 years. The most-recent trade in Elite Pharmaceuticals Inc is the acquisition of 340,954 shares on February 3, 2011, which cost Jeffrey A Whitnell around $13,638.
Insider Trading History of Jeffrey A Whitnell
- 1
Jeffrey A Whitnell Trading Performance
GuruFocus tracks the stock performance after each of Jeffrey A Whitnell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey A Whitnell is 180%. GuruFocus also compares Jeffrey A Whitnell's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey A Whitnell within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeffrey A Whitnell's insider trading performs compared to the benchmark.
Performance of Jeffrey A Whitnell
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 20 | | | | | |
| Relative Return to S&P 500(%) | 18.17 | | | | | |
Jeffrey A Whitnell Ownership Network
Ownership Network List of Jeffrey A Whitnell
Ownership Network Relation of Jeffrey A Whitnell
Jeffrey A Whitnell Owned Company Details
What does Elite Pharmaceuticals Inc do?
Who are the key executives at Elite Pharmaceuticals Inc?
Jeffrey A Whitnell is the director of Elite Pharmaceuticals Inc. Other key executives at Elite Pharmaceuticals Inc include Executive VP of Operations Douglas Plassche , CFO & Secretary & Treasurer Mark N Pellegrino , and Chief Commercial Officer Kirko Kirkov .
Elite Pharmaceuticals Inc (ELTP) Insider Trades Summary
Over the past 18 months, Jeffrey A Whitnell made no insider transaction in Elite Pharmaceuticals Inc (ELTP). Other recent insider transactions involving Elite Pharmaceuticals Inc (ELTP) include a net sale of 1,133,932 shares made by Douglas Plassche ,
In summary, during the past 3 months, insiders sold 1,133,932 shares of Elite Pharmaceuticals Inc (ELTP) in total and bought 0 shares, with a net sale of 1,133,932 shares. During the past 18 months, 1,133,932 shares of Elite Pharmaceuticals Inc (ELTP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,133,932 shares.
Elite Pharmaceuticals Inc (ELTP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Elite Pharmaceuticals Inc Insider Transactions
Jeffrey A Whitnell Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey A Whitnell. You might contact Jeffrey A Whitnell via mailing address: C/o Elite Pharmaceuticals, Inc, 165 Ludlow Avenue, Northvale Nj 07647.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
